Clinical Trials Directory

Trials / Completed

CompletedNCT03548805

Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma

Randomized Controlled Study to Evaluate Safety and Efficacy of Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
L.V. Prasad Eye Institute · Academic / Other
Sex
All
Age
10 Years – 40 Years
Healthy volunteers
Not accepted

Summary

To the best of Investigator knowledge, no studies to this date have compared the safety and efficacyof ologen® Collagen Matrix to MMC in exaggerated healing response among JOAG patients. Given that,filtration surgery is usually less successful in patients with juvenile glaucoma; the purpose of this study is to compare these two adjuvant therapies in exaggerated healing response among JOAG patients. Investigator hypothesis is that trabeculectomy with ologen® Collagen Matrix would be as effective as MMC in IOP control, with prominent bleb morphology as compared to MMC bleb.

Detailed description

Standard trabeculectomy All trabeculectomy surgeries will be performed under peribulbar anesthesia.Under aseptic surgical technique, superior rectus suture will be placed using 4-0 silk and a fornix-based conjunctival flap will be performed. Sub-Tenon dissection and hemostasis may be performed as required.A half-thickness 4 x 4mm rectangular/ triangular scleral flap will be dissected up to clear cornea, and a 2 × 2 mm deep scleral block will be excised and peripheral iridectomy will be performed. The scleral flap will be closed with one or two 10-0 nylon sutures and conjunctiva will be closed with 8-0 vicryl suture. Releasable sutures may be applied to the scleral flap if needed. ologen® Collagen Matrix ologen® Collagen Matrix approved by Indian health authority with registration numberof MD-1517 (valid till Mar-15-2018) will be provided by Aeon Ajanta India Pvt. Ltd. free of cost for this clinical research only. The following table summarizes the model number, shape and manufacturer of ologen® Collagen Matrix to be used in this clinical research. Product Model Shape Size Manufacturer Country of Origin Product Registration ologen® Collagen Matrix 830601 Round cylindrical 6mm (diameter) x 2mm (thickness) Aeon Astron Europe B. V. The Netherlands MD-1517 (valid till Mar-15-2018) Mitomycin C Mitomycin-C Kyowa®; Kyowa Hakko Kogyo Co., Ltd. will be used. 0.02% solution of MMC will be prepared freshly on the day of planned surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREologen® Collagen MatrixOlogen is a collagen matrix used to modulate wound healing in the postoperative period to promote diffuse blebs
PROCEDURETrabeculectomy with low dose mitomycin CTrabeculectomy with low dose MMC

Timeline

Start date
2018-08-16
Primary completion
2023-04-01
Completion
2023-05-19
First posted
2018-06-07
Last updated
2023-12-12

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03548805. Inclusion in this directory is not an endorsement.